Michael Ohlmeyer
Impact in
- Molecular Biology top 5%
- Protein Degradation and Inhibitors
- Chemical Synthesis and Analysis
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
-
- Protein Degradation and Inhibitors 6
- Protein Tyrosine Phosphatases 5
- PI3K/AKT/mTOR signaling in cancer 4
- Chemical Synthesis and Analysis 4
- Histone Deacetylase Inhibitors Research 4
- Ubiquitin and proteasome pathways 3
- Co-authors
- Lawrence W. Dillard (4 shared papers)W. Clark Still (2 shared papers)John Reader (3 shared papers)Ming‐Ming Zhou (8 shared papers)Michael Wigler (1 shared paper)R. N. Swanson (2 shared papers)Guangtao Zhang (5 shared papers)Andrew R. Clark (1 shared paper)
- Journals
- Journal of Biological Chemistry (4 papers)Cancer Research (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Proceedings of the National Academy of Sciences (3 papers)American Journal of Respiratory Cell and Molecular Biology (2 papers)
- Partner nations
- United StatesUnited KingdomFinland
In The Last Decade
Michael Ohlmeyer
51 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 114
- Molecular Biology 1.6k
- Hematology 230
- Oncology 271
- Organic Chemistry 285
- Radiology, Nuclear Medicine and Imaging 199
Countries citing papers authored by Michael Ohlmeyer
This map shows the geographic impact of Michael Ohlmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ohlmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ohlmeyer more than expected).
Fields of papers citing papers by Michael Ohlmeyer
This network shows the impact of papers produced by Michael Ohlmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ohlmeyer. The network helps show where Michael Ohlmeyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Ohlmeyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 376 | |
| 2 | 2013 | 194 | |
| 3 | 2012 | 173 | |
| 4 | 2014 | 169 | |
| 5 | 2013 | 108 | |
| 6 | 2018 | 103 | |
| 7 | 1995 | 94 | |
| 8 | 1995 | 83 | |
| 9 | 2019 | 77 | |
| 10 | 2012 | 71 | |
| 11 | 2018 | 63 | |
| 12 | 2015 | 55 | |
| 13 | 2019 | 47 | |
| 14 | 2019 | 47 | |
| 15 | 2020 | 43 | |
| 16 | 2009 | 33 | |
| 17 | 2021 | 30 | |
| 18 | 2015 | 27 | |
| 19 | 2014 | 27 | |
| 20 | 1999 | 26 |
About Michael Ohlmeyer
Michael Ohlmeyer is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Organic Chemistry, Oncology and Genetics, having authored 52 papers that have together received 2.1k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (6 papers), Protein Tyrosine Phosphatases (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Chemical Synthesis and Analysis (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Glioma Diagnosis and Treatment (4 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Molecular Biology (1.6k citations), Hematology (230 citations), Oncology (271 citations), Organic Chemistry (285 citations) and Radiology, Nuclear Medicine and Imaging (199 citations). Michael Ohlmeyer has collaborated with scholars based in United States, United Kingdom and Finland. Frequent co-authors include Lawrence W. Dillard, W. Clark Still, John Reader, Ming‐Ming Zhou, Michael Wigler, R. N. Swanson, Guangtao Zhang, Andrew R. Clark, John J. Baldwin and Ian Henderson. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, Bioorganic & Medicinal Chemistry Letters, Proceedings of the National Academy of Sciences and American Journal of Respiratory Cell and Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.